Eventide Asset Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.53M Buy
+435,450
New +$6.41M 0.08% 180

Other funds holding MTRI

Eventide Asset Management's MTRI Position: Q3 2026 in Review

Eventide Asset Management opened a new position in Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026: 435,450 shares worth $5.53M. The stake represents 0.08% of the portfolio and ranks #180 among its holdings.

16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Eventide Asset Management held 435,450 shares of Mentari Therapeutics, Inc. Common Stock worth $5.53M as of Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock was a new Eventide Asset Management position in Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock made up 0.08% of Eventide Asset Management's portfolio in Q3 2026, its #180 holding.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.